Research Reports
Martin & Harris Unlisted Shares
Martin & Harris Share Price
PHYSICAL
PUBLIC LIMITED
Price Chart
1W
1M
1Y
MAX
High
₹1,930
Low
₹820
Return
-52.33%
Buy Sell Martin & Harris Unlisted Shares
As of May 24, 2026, Martin and Harris Laboratories, Unlisted Shares are trading at ₹767.60 per share and face value is ₹10.00/share, with a 52-week high of ₹920.00 and 52-week low of ₹920.00. The minimun lot size is 220 shares, and the shares are traded on NSDL.
ISIN
INE03VV01015
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
10
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
39,96,040
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
306.74 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Profit After Tax
40.43 Cr
It is the final profit left over after subtracting all operating and non operating items from net revenue.
Total Revenue
146.15 Cr
Gross income refers to the total income earned by an individual on a pay check before taxes and other deductions. It comprises all incomes received by an individual from all sources – including wages, rental income, interest income, and dividends.
P/E
7.59
It is a valuation parameter that measures the company's current share price relative to its per-share earnings. Generally, high P/E is Overvalued & low P/E is Undervalued.
P/B
0.55
It shows the relationship between the current price and the book value of each share. A lower P/B ratio can mean that the stock is undervalued.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Pharmaceuticals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Micro Cap
Category is defined as a class or division of things regarded as having particular shared characteristics.
Cashflow - Operations
19.57 Cr
It indicates the amount of money a company brings in from its ongoing and regular operations over a fixed period of time.
About Martin & Harris
- Established in 1993,Martin and Harris Labs Ltd. is a vertically integrated biopharmaceutical laboratory offering expertise in Drug Development and Pharmaceutical Manufacturing. A team of competent scientists providing innovative solutions for drug development, along with state-of-the-art manufacturing facilities work passionately towards providing high quality end products and services to ensure complete customer satisfaction.
- The company has extensive manufacturing plants in Roorkee and Gagreth which have been built in accordance with the WHO GMP guidelines and these have separate quality control units and quality assurance functions to monitor the manufacturing quality of their products.
- Martin and Harris Laboratories Ltd. operates state-of-the-art manufacturing facilities located at prime locations of the country in order to serve their domestic & International markets. These units have a multi-decade experience of manufacturing different complex dosage forms and specialty formulations
- Pharmaceutical, medical, chemical, and botanical product manufacture are the main activities of Martin & Harris Laboratories Ltd.
- In addition to its primary pharmaceutical business, it manages its money by investing in various opportunities that yield strong returns, such as mutual funds, listed and unlisted stocks, etc. Delite Infrastructure Limited, an investment arm of Martin & Harris, handles all the related operations.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Martin & Harris Media
News
Articles
Videos
Frequently Asked Question (FAQs)
Where can I find the annual report of Martin and Harris Laboratories Ltd?
The annual report of Martin and Harris Laboratories Ltd is available in the annual report section.
How to buy Martin and Harris Laboratories Unlisted Shares?
Please find below the procedure for buying Martin and Harris Laboratories Unlisted Shares at Planify.
• 1. You confirm booking of Martin and Harris Laboratories Unlisted Shares with us at a trading price.
• 2. You provide your client master report (ask the broker if not available) along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
• 3. We will provide the bank details.
• 4. You need to transfer funds in that account.
• 5. Payment has to be done in RTGS/NEFT/IMPS CHEQUE TRANSFER. No CASH DEPOSIT.
• 6. Payment has to be done from the same account in which shares are to be credited.
• 7. We will transfer the shares in 24 hours if funds are credited before 2 pm.
Important Note: Please note that the lock-in period for selling Martin and Harris Laboratories Unlisted Shares is 6 months after listing. Hence you can’t sell Martin and Harris Laboratories Unlisted Shares which you bought in Pre-IPO for 6 months after its listing. i.e. You can sell it only after 6 months calculated from the listing date.
What is the lock-in period of Martin and Harris Laboratories Unlisted Shares?
Lock-in period of Martin and Harris Laboratories Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Martin and Harris Laboratories Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Martin and Harris Laboratories Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
See More
Martin & Harris
₹ 767.6
